Schering-Plough/Merck File Claritin, Singulair Combination
This article was originally published in The Pink Sheet Daily
NDA has been accepted by FDA for a standard 10-month review.
You may also be interested in...
Sales of Vytorin and Zetia climb 48 percent to $1.2 billion during the first quarter.
The virtual J.P. Morgan Healthcare meeting was missing the usual energy but still had substance.
US vaccination campaign will pick up speed now that access is broadening, leaders from Operation Warp Speed, Pfizer, Moderna, McKesson and CVS Health say at a J.P. Morgan panel discussion.